Covered recipient · General Payments record
RYAN W LAHEY
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
This page merges CMS profile IDs 7229794, 8806742 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2019–2024
$1,787.72
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.71 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $151.44 | 4 |
| Kiniksa Pharmaceuticals International, plc | $15.77 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.12 | 1 |
| Amgen Inc. | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.38 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115844343 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.31 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101802552 | CMS |
| E.R. Squibb & Sons, L.L.C. | $11.60 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101802559 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.50 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101802614 | CMS |
| E.R. Squibb & Sons, L.L.C. | $110.03 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101802730 | CMS |
| Kiniksa Pharmaceuticals International, plc | $15.77 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154865751 | CMS |
| Novartis Pharmaceuticals Corporation | $14.12 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086988252 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs
- 7229794, 8806742
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.